發(fā)布時(shí)間：2018-07-23 20:33

【摘要】：正本刊投稿須知刊登在當(dāng)年第1期,請(qǐng)投稿者遵照寫稿。1征稿內(nèi)容《中國新藥與臨床雜志》是集中報(bào)道國內(nèi)外新藥的全國性醫(yī)藥科技學(xué)術(shù)期刊,著重報(bào)道藥物的臨床研究和臨床應(yīng)用,介紹國內(nèi)外新藥的進(jìn)展及動(dòng)態(tài)。主要登載:(1)新藥(包括老藥新用)的臨床試驗(yàn)(Ⅰ期、Ⅱ期、Ⅲ期、Ⅳ期);(2)生物等效性試驗(yàn);(3)新藥臨床前研究(藥理、毒理、藥動(dòng)學(xué)、
[Abstract]:The guidelines for submission of this journal are published in the first issue of that year. According to the first issue of the year, the Chinese Journal of New drugs and Clinical reports is a national academic journal of medicine and science and technology that focuses on domestic and foreign new drugs. This paper reports the clinical research and clinical application of drugs, and introduces the progress and development of new drugs at home and abroad. Main publications: (1) bioequivalence test for clinical trials of new drugs (including old ones) (stage 鈪，

本文編號(hào)：2140561